Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Global Blood Plasma Market (Immunoglobulin, Albumin, Factor VIII, & Alpha 1): (2019-2023)North America is the largest market for blood plasma due to its advanced infrastructure which has helped in increasing plasma collection over the time.
By: Koncept Analytics The global blood plasma market is broadly segmented into four types which are Immunoglobulin, Albumin, Factor VIII, Alpha 1 and Others. Increased recognition and treatment of primary immunodeficiency (PI), use in new indications, and increasing consumption in low IG-use countries has driven the growth of immunoglobulin segment. North America is the largest market for blood plasma due to its advanced infrastructure which has helped in increasing plasma collection over the time. The emerging economies like China have showed huge potential with increased imports of Albumin. Rising use of immunoglobulin and increasing incidence of immune and bleeding disorders propelled the demand for immunoglobulin in the Unites States. Scope of the report: • The report provides a comprehensive analysis of the global blood plasma market, segmented into Immunoglobulin, Albumin, Factor VIII, Alpha 1 and Others. • The major regional markets (North America, Europe and APAC) have been analyzed, along with country coverage of the United States. • The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth. • The competitive landscape of the market, along with the company profiles of leading players (Takeda Pharmaceutical, CSL Limited, Grifols S.A., Octapharma, Inc., ADMA Biologics and China Biologics) are also presented in detail. For more Information: http://www.konceptanalytics.com/ Koncept Analytics Vikas Gupta (Business Development Manager) FFCS-36, Ansal Plaza Vaishali, Ghaziabad U.P - 201010 Tele: +91-120-4130959 Mobile: +91-9871694789 Mail ID – vikas@konceptanalytics.com End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|